Objective. Millions of patients experience the disabling hand manifestations of rheumatoid arthritis (RA), yet few hand-specific instruments are validated in this population. Our objective was to assess the reliability, validity, and responsiveness of the Michigan Hand Questionnaire (MHQ) in patients with RA. Methods. At enrollment and at 6 months, 128 RA patients with severe subluxation of the metacarpophalangeal joints completed the MHQ, a 37-item questionnaire with 6 domains: function, activities of daily living (ADL), pain, work, aesthetics, and satisfaction. Reliability was measured using Spearman's correlation coefficients between time periods. Internal consistency was measured using Cronbach's alpha. Conclusion. The MHQ is easily administered, reliable, and valid to measure rheumatoid hand function, and can be used to measure outcomes in rheumatic hand disease.
INTRODUCTION
Rheumatoid arthritis (RA) is a systemic inflammatory autoimmune disease that results in substantial disability and premature death for more than 1 million individuals in the US (1) . Rheumatic hand disease is caused by progressive and irreversible inflammation of the synovial tissue, and joint destruction occurs early in the course of disease. Hand deformity and dysfunction is the most common manifestation of RA; 70% of patients with RA experience disfiguring and painful rheumatoid hand deformities. Up to 30% of patients have radiographic evidence of disease at the time of diagnosis, and more than 60% have radiographic joint changes within 2 years of diagnosis (2) . Unlike other chronic diseases, such as osteoarthritis or hypertension, patients are typically diagnosed with RA in young adulthood, and this disease profoundly interferes with their future work productivity, their ability to perform activities of daily living (ADL), and their social interactions. On a societal level, the effect of these lost wages and expensive medical therapies consumes approximately $3.6 billion per year (3, 4) . Unfortunately, a standardized, hand-specific instrument to measure rheumatoid hand function remains elusive, and there are few accepted guidelines for defining hand disability among RA patients.
A variety of methods have been used to describe health outcomes related to the hand manifestations of RA. These have ranged from objective measures, such as painful joint counts or grip strength, to more subjective measures, such as patient satisfaction scores and quality of life measures. Although single, objective measures of function, such as range of motion, degree of finger extension lag, grip strength, and pinch power, are relatively simple to obtain, they often do not capture the full extent of patient disability. More complex functional tests can include a battery of tasks, such as the Jebsen-Taylor Test, the Grip Ability Test, or the Arthritis Hand Function Test (5) (6) (7) . These may provide a better assessment of difficulty with ADL, but often do not account for other important end points such as pain, aesthetics, and patient satisfaction (8) .
Patient perception of health status as measured by selfadministered instruments has been shown to be a better predictor of functional status and disability compared with objective measures (9) . Many instruments have been used to define patient-related outcomes in patients with RA, ranging from general quality of life to hand-specific surveys. General health assessment instruments, such as the visual analog scale, the Short Form 36 and its derivations, and the Health Assessment Questionnaire, may offer a global assessment of functioning, but they are not sensitive to detect the amount of patient disability related specifically to RA or to hand dysfunction (8,10 -12) . Other authors have used hypothetical scenarios to explore patient-related outcomes, using utility measures to estimate future quality of life. Although such models are useful in decision analyses, they are often difficult to implement in clinical practice and the concepts may be challenging for the patients to grasp (13, 14) . An ideal instrument should be hand specific, and include not only patient perception of function, but also measures of pain, satisfaction, and hand appearance.
We have prospectively evaluated patients with RA from 3 centers in the US and the UK to determine patient outcomes following surgical intervention (silicone arthroplasty) for metacarpophalangeal (MCP) joint deformity using the Michigan Hand Questionnaire (MHQ). We have achieved excellent long-term followup in this sample, and we have a unique opportunity to describe the reliability, validity, and responsiveness of the MHQ in patients with RA. The MHQ is a self-administered questionnaire that contains 37 items and requires approximately 15 minutes to complete, and has been used successfully in the RA population in prior work (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) . We hypothesize that the MHQ will accurately and reliably define rheumatoid hand performance, and effectively measure clinical change in hand function over time.
SUBJECTS AND METHODS
The study sample consisted of patients diagnosed with RA by their rheumatologists and referred to one of the following 3 institutions: The University of Michigan (Ann Arbor, Michigan), the Curtis National Hand Center (Baltimore, Maryland), and the Pulvertaft Hand Centre (Derby, UK). The study sample is part of a larger prospective study supported by the National Institutes of Health regarding the use of silicone MCP joint arthroplasty (SMPA) for joint deformities due to RA, which has been described in detail elsewhere (26, 27) . Patients were included in the study if they were diagnosed with RA, had severe MCP joint deformity, and were deemed appropriate candidates for surgical reconstruction. Additionally, subjects were eligible if they were age Ն18 years and able to complete the study questionnaire in English. Patients were excluded from the study if their comorbid conditions prohibited surgery, they experienced additional hand conditions (swan-neck and boutonniere deformities, extensor tendon ruptures) that would require intervention beyond SMPA, or they had previously undergone MCP joint replacement. After enrollment, participants either elected to receive an SMPA or remained as controls. Data were collected from the subjects at the time of enrollment and at a 6-month followup time. The study protocol was approved by the Institutional Review Boards at the University of Michigan, the Curtis National Hand Center, and the Pulvertaft Hand Centre.
All of the subjects completed the MHQ, which has been previously validated for use in a wide range of patient samples (15) (16) (17) (18) (19) (20) . The MHQ yields an overall summary score of hand function, as well as scores for 6 specific scales: hand function, ability to complete ADL, pain, work performance, aesthetics, and patient satisfaction. Scores for each domain range from 0 -100, and higher scores indicate better performance for all domains with the exception of pain.
The subjects also completed the Arthritis Impact Measurement Scales 2 (AIMS2) questionnaire, a 45-item, selfadministered outcomes tool designed to assess health status in patients with inflammatory arthritis and osteoarthritis (28) . The AIMS2 is designed to provide a global, self-reported assessment of patient health status and yields information in 4 domains, including physical functioning, affect, symptom, and social interaction. Scores range from 1-10, with lower scores reflecting better health.
All of the subjects underwent the following assessments to provide objective and reproducible measures of hand function at baseline and subsequent followup: grip strength, lateral pinch, 2-point pinch, and 3-point pinch, all measured in kilograms. Subjects also completed the Jebsen-Taylor Test, which is a 7-part, standardized test designed to assess a subject's ability to complete everyday hand-related tasks (29) . The writing portion was not included in this analysis due to difficulty of interpretation relating to hand dominance. Time to complete each task was measured in seconds.
Outcomes. Reliability. Reliability was defined as the ability of an instrument to consistently or precisely measure a concept of interest (30) . In this study, we measured 2 aspects of reliability of the MHQ: the test-retest reliability of the MHQ and the internal consistency of the 6 scales within the MHQ. Test-retest reliability implies that the survey yields similar results from consecutive administration to a subject. To determine the test-retest reliability of the MHQ, we compared responses for each domain of the MHQ at baseline and at the 6-month followup interval. We used responses regarding the symptomatic hand of the control patients who did not undergo SMPA and the nonoperated hand of the SMPA patients. The degree of correlation between the consecutive responses was assessed using Spearman's correlation coefficients. Additionally, we used paired t-tests to determine the average difference in score for each domain between these time periods to determine if these means were significantly different. A mean difference of 0 indicates perfect test-retest reliability.
We determined the internal consistency, or homogeneity, of the items included in each scale of the MHQ by calculating Cronbach's alpha for each of the 6 scales in the MHQ. Cronbach's alpha is a measure of the homogeneity of items within a scale, and is based on the number of items included and their degree of correlation according to the following formula:
where N ϭ the number of items in the scale, ϭ the average variance between subjects in the sample, and c ϭ the average covariance between items among the subjects in the sample. Cronbach's alpha values range from 0 -1, with higher values indicating greater internal consistency. In general, Cronbach's alpha values between 0.6 and 0.8 are considered acceptable (31) . Values greater than 0.8 indicate that there may be redundancy of items in the scale. Cronbach's alpha values that are less than 0.6 indicate that items in the scale are not adequately related to one another to measure a concept (31) . The MHQ queried patients regarding their performance in each domain separately for the right and left hand, and we stratified our analysis by hand dominance.
Validity. Validity was defined as the ability of an instrument to accurately measure a concept of interest. For example, patients who score poorly on the MHQ, indicating worse function, would be expected to also have poor performance in other aspects of hand functioning, such as strength and dexterity with specific tasks. Three important types of validity exist: content validity, criterion validity, and construct validity.
Content validity, or face validity, describes the extent to which an instrument appears logical or capable of measuring an outcome of interest to experts within a particular field. The MHQ was developed with strict attention to psychometric principles. It has been validated in a variety of acute and chronic hand conditions and translated into several languages, and therefore is considered appropriate to measure outcomes among patients with RA (16, 17, 19, 20, 32) .
Criterion validity describes the extent to which an instrument compares with the accepted reference standard. For patients with RA, there is no established standard to measure health outcomes related to hand dysfunction. Therefore, construct validity is often used to establish the validity of outcomes questionnaires.
Construct validity describes the extent to which the scales in the survey instrument behave as expected. For example, patients who report high pain scores would be expected to endorse difficulty with functioning, ADL, and work performance. We established a priori hypothetical relationships between the scales of the MHQ and used Spearman's correlation coefficients to test construct validity against each scale of the MHQ. Additionally, we compared responses to the MHQ among SMPA and control patients with their responses to the AIMS2 questionnaire, an existing, validated measure of health status in RA patients, in order to establish the construct validity.
Responsiveness. Responsiveness was defined as the ability of an instrument to detect important changes in an outcome of interest over time (33) . Because the greatest change after surgery occurs within 6 months after SMPA surgery, we used paired t-tests to compare mean scores at baseline and at the 6-month followup for each scale and for the summary score. In order to compare the change in scores over time using a standardized method, we calculated the standardized response mean (SRM) for each scale of the MHQ. Ideally, a more sensitive instrument should have a higher SRM (34) . Using Cohen's effect size definition, we assumed that an SRM of 0.2 corresponds to a small effect size, 0.5 corresponds to a medium effect size, and 0.8 corresponds to a large effect size (35) . The responsiveness of the MHQ was determined separately for SMPA patients and for control patients. Finally, we compared the responsiveness of the MHQ with the responsiveness of each domain of the AIMS2 survey as an additional validation measure.
Statistical analysis. Descriptive statistics were generated to describe the sociodemographic characteristics of the study sample. Statistical significance was set at an alpha level of 0.05. All of the analyses were conducted using Stata, version 10.1. (StataCorp).
RESULTS
The characteristics of the study sample are detailed in Table 1 . Of the 160 patients enrolled, 128 patients completed followup at 6 months, with a loss to followup rate of 20%. The majority of the patients were white (97%), women (74%), and right-hand dominant (91%), with a mean age of 60.9 years. Approximately 26% had less than a high school education, and 70% earned an annual income of less than $60,000 per year. The test-retest reliability of the MHQ was measured by calculating the correlation between responses to the MHQ at baseline and at 6 months of followup (Table 2) . Responses regarding the affected hand of the control patients and the nonoperated hand of the case patients were used for this portion of the analysis, and the results are stratified to reflect the differences between these 2 groups. Overall, correlations between responses for each time period were high, indicating good reliability of the MHQ. Among the control patients, responses for work performance were most strongly correlated (r ϭ 0.75, P Ͻ 0.001), as well as aesthetic appearance (r ϭ 0.70, P Ͻ 0.001), patient satisfaction (r ϭ 0.70, P Ͻ 0.001), and the summary MHQ score (r ϭ 0.75, P Ͻ 0.001). Responses regarding function (r ϭ 0.63, P Ͻ 0.001) and ADL (r ϭ 0.63, P Ͻ 0.001) were the least strongly correlated (r ϭ 0.61). Among the case patients, responses were highly correlated for ADL (r ϭ 0.79, P Ͻ 0.001) and patient satisfaction (r ϭ 0.76, P Ͻ 0.001). Responses regarding aesthetics were the least well correlated (r ϭ 0.50, P Ͻ 0.001). Figure 1 describes the mean differences between scores for each scale between time points of administration. Figure 1A describes the mean difference in responses for the affected hand of control patients. Overall, the differences in score between each administration were small, without statistically significant differences between the time periods. Figure 1B describes the mean difference in responses regarding the nonoperated hand of the patients who underwent SMPA. Interestingly, responses regarding the control hand were significantly different between each time period for all domains, with the exception of pain. These patients reported higher improved scores regarding function (baseline mean 51.3, followup mean 60.5; P Ͻ 0.001), ADL (baseline mean 44.2, followup mean 56.7; P Ͻ 0.001), work (baseline mean 41.9, followup mean 52.3; P Ͻ 0.002), aesthetics (baseline mean 50.5, followup mean 59.7; P Ͻ 0.006), and patient satisfaction (baseline mean 44.2, followup mean 53.4; P Ͻ 0.001).
Reliability of the MHQ was also assessed by determining the internal consistency of items within each scale of the MHQ, as measured by Cronbach's alpha, stratified by hand dominance ( Table 3) . As described above, the ideal value for Cronbach's alpha should lie between 0.6 and 0.8. Cronbach's alpha values that are less than 0.6 indicate heterogeneity among items in the scale, and values greater than 0. 8 
To test the construct validity of the MHQ, we tested the responses to each scale against the other scales in the MHQ to determine if each scale behaves in an expected manner using Spearman's correlation coefficients (Table 4) . For example, we would expect a higher correlation between function and ability to complete ADL than between aes- thetics and ability to complete ADL. For the majority of scales, responses to the MHQ were correlated with the other scales in the expected direction. For example, function was more correlated with ADL (r ϭ 0.83), work performance (r ϭ 0.65), and pain (r ϭ Ϫ0.65) than with aesthetics (r ϭ 0.43). As expected, aesthetics was least correlated with work performance (r ϭ 0.38). Satisfaction was correlated most strongly with function (r ϭ 0.81) and ADL (r ϭ 0.73) than with pain (r ϭ Ϫ0.69), aesthetics (r ϭ 0.41), or work performance (r ϭ 0.54).
To further assess construct validity, we compared responses to each scale of the MHQ with responses to the AIMS2 domains, as well as objective measures of hand functioning ( Table 5) . As expected, function (r ϭ Ϫ0.63), ADL (r ϭ Ϫ0.77), work performance (r ϭ Ϫ0.64), pain (r ϭ 0.59), and summary MHQ score (r ϭ Ϫ0.74) were strongly correlated with the physical domain of the AIMS2 survey. The affect domain of the AIMS2 was most strongly correlated with the summary MHQ score (r ϭ Ϫ0.53), and the symptom domain of the AIMS2 was most strongly correlated with pain (r ϭ 0.70). The social domain was not well correlated with any of the MHQ scales. This suggests that the MHQ may not capture some elements of the effect of RA on social interaction and patient affect that are measured by the AIMS2.
The MHQ was also correlated well with objective measures of functioning, including grip and pinch strength and the Jebsen-Taylor score ( Table 5 ). The function, ADL, and satisfaction domains were most highly correlated with these measures; aesthetics was the least correlated. For example, correlations were highest with Jebsen-Taylor scores (function r ϭ Ϫ0.50, ADL r ϭ Ϫ0.50, satisfaction r ϭ Ϫ0.38; P Ͻ 0.001) and palmar pinch (function r ϭ 0.45, ADL r ϭ 0.47, satisfaction r ϭ 0.32; P Ͻ 0.001). Summary MHQ score was most correlated with grip strength (r ϭ 0.34, P Ͻ 0.12), palmar pinch (r ϭ 0.37, P Ͻ 0.001), and Jebsen-Taylor score (r ϭ Ϫ0.46, P Ͻ 0.001).
We calculated the responsiveness of the MHQ to detect clinical change in hand function over the 6-month study period. The summary MHQ score and scores for each scale of the MHQ at baseline and at the 6-month followup and the SRMs for each scale of the MHQ are shown in Table 6 . As expected, the MHQ demonstrated strong responsiveness to clinical change in the group of patients who underwent SMPA. SRMs were high for function (SRM 1.42), ADL (SRM 0.89), aesthetic appearance (SRM 1.23), satisfaction (SRM 1.76), and the summary MHQ score (SRM for all of the measures over a 6-month time period were modest, and there were no statistically significant differences between mean scores for any measure. Work performance was the most responsive measure over time (SRM 0.14), although this is overall a very low effect. Because these patients did not undergo surgical reconstruction, we would not expect to see a large change in their hand performance over this brief period of time.
DISCUSSION
The MHQ is a hand-specific outcome measurement tool that has been extensively studied in a variety of acute and chronic hand conditions, including nerve compression, distal radius fractures, Dupuytren's disease, and osteoarthritis (15) (16) (17) (18) (19) (20) . The MHQ is ideal for use in the RA population because it specifically encompasses measures of aesthetics and pain control, which have been demonstrated to be important motivators for surgical therapy among patients with RA (36, 37) .
The MHQ demonstrated good test-retest reliability among the control patients, with minimal change in scores between survey administrations without statistically significant differences. Interestingly, patients who underwent SMPA reported significantly higher improved scores for the control, nonoperated hand across all of the MHQ domains with the exception of pain. The perioperative experience has a profound influence on a patient's perception of their disease and disability. Other authors have also reported similar phenomena among patients with other chronic health conditions such as paralysis and renal failure (38 -40) . These biases should be taken into consideration when using any health outcomes instrument, including the MHQ.
Overall, the 6 scales of the MHQ demonstrated excellent internal consistency, although item redundancy exists within the MHQ domains. This indicates that the MHQ may be well suited for item reduction in the future, which may improve response rates by shortening the time to complete the survey. The ADL, work performance, and pain scales of the MHQ were correlated in the expected direction with the AIMS2 instrument, particularly with respect to the physical domain. The function, ADL, satisfaction, and summary MHQ score were well correlated in the expected direction with objective measures of hand functioning, including grip and pinch strength and the Jebsen-Taylor Test score. Finally, the MHQ showed excellent responsiveness among patients who underwent SMPA arthroplasty, and it was able to detect change in hand performance over a 6-month time period. As expected, changes in hand performance as measured by the MHQ among patients who had not undergone surgery were modest over the 6-month followup period.
Other methods for assessing the extent of disability related to rheumatic hand disease include describing the extent of anatomic deformity using scoring algorithms based on clinical examination or radiographic evidence of joint destruction. For example, the Hand Index uses simple hand measurements of the span and lateral height of the open and closed hand to create a standardized measure of deformity (41) . The Joint Alignment and Motion Scale score and the mechanical joint score can be used to define hand deformity and dysfunction at the bedside, but are subject to observer variation (42, 43) . Radiographic evidence of disease and disease progression has been defined by other instruments such as the Sharp score (44). These measures have the advantage of documenting the progression of disease over time, but do not adequately predict the clinical manifestations of disease such as pain, occupational disability, and the need for joint replacement (45) . Although describing anatomic deformity may be helpful as part of a global assessment of disability, it is problematic when taken alone because many patients are able to retain excellent hand functioning despite deformity. Pain, joint instability, and exercise tolerance are more predictive of physical functioning and general health perception among patients with RA than clinical or radiologic joint appearance (8, 46) .
To our knowledge, the MHQ is the first self-administered instrument validated in patients with RA that comprehensively gathers information on functional ability and the ability to complete daily and occupational activities, as well as patient satisfaction, pain, and aesthetic hand appearance. It is the only questionnaire validated in this population that can adjust for hand dominance and the differences in hand disability between both hands. The MHQ queries patients regarding their left and right hands separately in each performance domain. Furthermore, the MHQ includes a separate item regarding hand dominance (right-hand dominant, left-hand dominant, or both). Responses to this item can then be used to stratify patients by hand dominance for subsequent analyses, or to adjust for hand dominance in multivariate analyses. Several upper extremity-specific instruments have been used to measure hand function in patients with rheumatism. The Disabilities of the Arm, Shoulder, and Hand questionnaire has been used to study patients with rheumatism, but its validity and responsiveness have not been documented in this population (47) . Furthermore, it does not make a distinction between right and left hand disability and focuses on the entire upper extremity, not specifically hand dysfunction. The Patient-Rated Wrist Evaluation Questionnaire has been used to study pain and function among RA patients, but focuses primarily on wrist, not hand, dysfunction, which frequently coexist in patients with rheumatism (48) . The Cochin Rheumatoid Hand Disability scale has been developed to measure the effectiveness of surgery on rheumatoid hand functioning with respect to ADL, and has been shown to be valid in this population and sensitive to changes in disease state (49, 50) . It does not, however, include important aspects of the patient experience, including an assessment of pain, patient satisfaction, or aesthetics (50, 51) .
Our findings are consistent with previous, smaller studies regarding the use of the MHQ to describe hand disability among patients with RA. In comparison with the Australian/Canadian Osteoarthritis Hand Index and the Sequential Occupational Dexterity Assessment, the MHQ yields reproducible results and is uniquely suited to measure outcomes in patients with RA because it can discern disability in both hands (24) . Although the MHQ was less responsive to clinical change among control patients because, expectedly, the control patients should not have changes in hand performance, it demonstrated excellent responsiveness among patients undergoing SMPA. These results are consistent with prior work using the MHQ to measure outcomes in Dutch patients with RA. In this study, the MHQ demonstrated excellent responsiveness to clinical change over time, particularly in the domains of patient satisfaction and hand aesthetics (22) .
Our study has several notable limitations. First, criterion validity cannot be assessed because there is no previously accepted "gold standard" instrument for measuring hand function among patients with RA. Additionally, the progression of rheumatoid hand dysfunction may be too slow to detect appreciable clinical change, and longer followup may be needed to understand the responsiveness to change of the MHQ in patients who have not undergone surgery. However, we were able to demonstrate excellent responsiveness among patients who underwent surgical intervention. Finally, our sample size prevented us from stratifying our results based on disease severity and effects of medical and occupational therapies, which may have influenced our results. Our current data are limited by a lack of information regarding disease characteristics and medical therapies, such as laboratory values (e.g., C-reactive protein level) or the use of corticosteroids. Future studies will include such variables and will allow us to evaluate the performance of the MHQ in the context of these factors.
Nonetheless, this study demonstrates that the MHQ is an essential instrument to understand the extent of disability of rheumatic hand disease. The MHQ offers clinicians a systematic approach to defining patient disability. Additionally, the MHQ can be incorporated into future studies regarding the effectiveness of RA therapies because it offers a comprehensive assessment of hand functioning and patient-centered outcomes. In conclusion, the MHQ is an easily administered, reliable, valid tool to measure rheumatoid hand function, and an essential instrument to systematically guide clinical decision making and assess the quality of care of rheumatic hand disease.
